These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36201204)

  • 1. Novel Therapies on the Horizon of Hypertension Management.
    Blazek O; Bakris GL
    Am J Hypertens; 2023 Feb; 36(2):73-81. PubMed ID: 36201204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches in the treatment of hypertension.
    Oparil S; Schmieder RE
    Circ Res; 2015 Mar; 116(6):1074-95. PubMed ID: 25767291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newer alternatives for resistant hypertension: Beyond 2022 paradigms.
    Laffin LJ; Briasoulis A; Bakris GL
    Hellenic J Cardiol; 2023; 70():75-77. PubMed ID: 36739976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging concepts for patients with treatment-resistant hypertension.
    Eirin A; Textor SC; Lerman LO
    Trends Cardiovasc Med; 2016 Nov; 26(8):700-706. PubMed ID: 27381561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches.
    Unger T; Paulis L; Sica DA
    Eur Heart J; 2011 Nov; 32(22):2739-47. PubMed ID: 21951628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Molecules for Treating Resistant Hypertension: a Clinical Perspective.
    Azzam O; Kiuchi MG; Ho JK; Matthews VB; Gavidia LML; Nolde JM; Carnagarin R; Schlaich MP
    Curr Hypertens Rep; 2019 Sep; 21(10):80. PubMed ID: 31506798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Device Therapies for Resistant Hypertension.
    Hering D; Schultz C; Schlaich MP
    Clin Ther; 2016 Oct; 38(10):2152-2158. PubMed ID: 27671866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Drug Classes and Their Potential Use in Hypertension.
    Azizi M; Rossignol P; Hulot JS
    Hypertension; 2019 Nov; 74(5):1075-1083. PubMed ID: 31495277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent treatment-resistant hypertension and chronic kidney disease: another cardiovascular-renal syndrome?
    Vemulapalli S; Tyson CC; Svetkey LP
    Adv Chronic Kidney Dis; 2014 Nov; 21(6):489-99. PubMed ID: 25443574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.
    Voora R; Hinderliter AL
    Curr Hypertens Rep; 2018 Sep; 20(11):92. PubMed ID: 30194545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key advances in antihypertensive treatment.
    Paulis L; Steckelings UM; Unger T
    Nat Rev Cardiol; 2012 Mar; 9(5):276-85. PubMed ID: 22430830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition and Management of Resistant Hypertension.
    Braam B; Taler SJ; Rahman M; Fillaus JA; Greco BA; Forman JP; Reisin E; Cohen DL; Saklayen MG; Hedayati SS
    Clin J Am Soc Nephrol; 2017 Mar; 12(3):524-535. PubMed ID: 27895136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistant hypertension: a practical clinical approach.
    Muxfeldt ES; de Souza F; Salles GF
    J Hum Hypertens; 2013 Nov; 27(11):657-62. PubMed ID: 23636008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of resistant hypertension: state of the art.
    Wei FF; Zhang ZY; Huang QF; Staessen JA
    Nat Rev Nephrol; 2018 Jul; 14(7):428-441. PubMed ID: 29700488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel and nonpharmacologic approaches to cardio-protection in hypertension.
    Donazzan L; Mahfoud F; Linz D; Ewen S; Ukena C; Böhm M
    Curr Hypertens Rep; 2014 May; 16(5):430. PubMed ID: 24633844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New drug therapies interfering with the renin-angiotensin-aldosterone system for resistant hypertension.
    Monge M; Lorthioir A; Bobrie G; Azizi M
    J Renin Angiotensin Aldosterone Syst; 2013 Dec; 14(4):285-9. PubMed ID: 24222656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are there any new pharmacologic therapies on the horizon to better treat hypertension? A state-of-the-art paper.
    Habib GB; Basra SS
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):516-25. PubMed ID: 24790054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.
    Carey RM; Calhoun DA; Bakris GL; Brook RD; Daugherty SL; Dennison-Himmelfarb CR; Egan BM; Flack JM; Gidding SS; Judd E; Lackland DT; Laffer CL; Newton-Cheh C; Smith SM; Taler SJ; Textor SC; Turan TN; White WB;
    Hypertension; 2018 Nov; 72(5):e53-e90. PubMed ID: 30354828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, prognosis, and treatment of resistant hypertension.
    Smith SM
    Pharmacotherapy; 2013 Oct; 33(10):1071-86. PubMed ID: 23722533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.